Harpoon Therapeutics, Inc. (NASDAQ:HARP) Major Shareholder Merck & Co., Inc. Acquires 21,397,205 Shares
Harpoon Therapeutics, Inc. (NASDAQ:HARP Get Free Report) major shareholder Merck & Co., Inc. purchased 21,397,205 shares of the companys stock in a transaction that occurred on Monday...